Explore

Biotechnology-2019

23rd World Congress on Biotechnology 2019

Amsterdam, Netherlands
14 - 15 November 2019
The conference ended on 15 November 2019

Important Dates

Abstract Submission Deadline
22nd July 2019

About Biotechnology-2019

Conference Series is organizing a 23rd World Congress on Biotechnology on November 14-15, 2019 at Amsterdam, Netherlands. The theme of the conference is “Exploration of latest Applications in the field of Biotechnology”. Benefits: • Networking with experts in the field • Live streaming of your presentation through our websites and YouTube • e-Poster opportunity • Student delegate • Best poster competitions and young researcher competitions • Career guidance workshops to the graduates, doctorates and post-doctoral fellows

Call for Papers

23rd World Congress on Biotechnology, will be organized around the theme “Exploration of latest Applications in the field of Biotechnology” Biotechnology-2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Biotechnology-2019 Submit your abstract to any of the mentioned tracks. Register now for the conference by choosing an appropriate package suitable to you. Track 1:Pharmaceutical Biotechnology and Drug Design Track 2:Animal biotechnology Track 3:Industrial biotechnology Track 4:Plant and agriculture biotechnology Track 5:Nano-Biotechnology Track 6:Stem Cell Biotechnology Track 7:Environmental Biotechnology Track 8:Biotechnology Industries In The Market Track 9:Microfluidics For Biotechnology Track 10:Food Biotechnology Track 11:Marine Biotechnology Track 12:Cancer Biotechnology Track 13:Techniques Of Biotechnology Track 14:Protein Engineering Track 15:Recombinant DNA technology Track 16:Biosensors in biotechnology Track 17:Biodegradation and recycling Track 18:Biochemistry and Biophysics

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.